Skip to main content

Table 2 Differences in the transcription level of the OTUD family in pancreatic cancer and normal pancreatic tissues (TCGA and GTEx)

From: YOD1 serves as a potential prognostic biomarker for pancreatic cancer

Gene

ConMean

TreatMean

Log2FC

P-Value

FDR

OTUD1*

2.34

4.82

2.47

1.06E−52

6.36E−52

YOD1*

1.20

2.56

1.35

2.20E−50

8.75E−50

OTUD3

1.95

1.61

− 0.33

7.10E−14

9.13E−14

OTUD4

\

\

\

\

\

OTUD5*

9.94

13.71

3.76

1.53E−45

4.15E−45

OTUD6A

\

\

\

\

\

OTUD6B

1.77

2.19

0.41

1.17E−08

1.39E−08

ALG13

7.57

2.89

− 4.68

4.72E−53

3.16E−52